Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea

Exclusion Criteria

• •Allergies to components of investigational product and/or hypersensitivity to tetracyclines
• •Taken systemic therapy directed at improving rosacea, including antibiotics, within 30 days prior to baseline visit
• •Used topical rosacea treatment within 30 days prior to baseline visit
• •Have active ocular rosacea and/or blepharitis/meibomianitis requiring systemic treatment by an opthalmologist
• •Previously failed to have improvement of rosacea with appropriate use of systemic tetracycline family of antibiotics
• •Exposed to intense/excessive ultraviolet (UV) radiation within one week prior to baseline and/or who forsee unprotected and intense/excessive UV exposure during the course of the study
• •Have planned surgical procedures during the course of the study
• •Have used tetracycline antibiotics within 30 days prior to baseline visit or during study
• •At risk in terms of precautions, warnings, and contraindications